Company intelligence / Profile preview

Rex Medical

Conshohocken, Pennsylvania, United Statesrexmedical.com ↗

Ownership: Private
Development stage: Commercial

Overview

The company’s flagship product, the Revolution™ Peripheral Atherectomy System, has received FDA clearance for atherectomy and thrombus removal in peripheral arteries. The company focuses on developing ISO 13485-certified devices to address unmet clinical needs in cardiovascular, venous access, endosurgery, and oncology markets. Clinical results are not detailed publicly but regulatory clearance indicates safety and efficacy for intended uses.

Therapeutic areas: GastroenterologyCardiovascularOncology
Modalities: Device (specifically minimally invasive medical devices)
Industry: Therapeutic Medical Devices

Partnerships

Argon Medical Devices acquired three vascular technologies from Rex Medical in January 2016; otherwise no major ongoing partnerships disclosed.

Beyond the preview

Go deeper on Rex Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rex Medical.

Explore the full profile